Insys Therapeutics Reports First Quarter 2014 Results
$41.6 Million in Net Revenue Marks Fifth Consecutive Quarter of Revenue Growth; Three-for-Two Stock Split Increases Shares Outstanding to 34.2 Million SharesContinue reading
Insys Therapeutics Reports First Quarter 2014 Results
$41.6 Million in Net Revenue Marks Fifth Consecutive Quarter of Revenue Growth; Three-for-Two Stock Split Increases Shares Outstanding to 34.2 Million SharesContinue reading
Scientists have shown new genetic evidence that could strengthen the link between the role of dietary fats with colon cancer progression.Continue reading
CE Mark Gives SynCardia Systems, Inc. Control over Last Critical Component for SynCardia Heart ManufacturingContinue reading
Clinical Coordinator/Technical Writer
VisionGate Corporation
275 N. Gateway Dr. Phoenix, AZ 85034
VisionGate produces the Cell-CT™, the world’s first 3D cellular imaging device based upon optical projection tomography, which renders cells with sub-micron, isometric resolution. Based on 3D images of cells from sputum, VisonGate aims to improve patient health with the world’s first, non-invasive, diagnostic test for early lung cancer detection: LuCED™. VisionGate is expanding its team in Phoenix that will carry the development and commercialization of its products forward.
Position Summary
VisionGate is currently commercializing its LuCED test for early detection of lung cancer. We are also partnering with several institutions locally and internationally who will supply study specimens that will be used to evaluate the LuCED test. Development of other tests based on the Cell-CT are being considered or are in progress. To facilitate our development and clinical programs we seek to add a staff member who will coordinate these clinical studies. Responsibilities will also involve creation of clinical study protocols and reports, abstracts for publications, and other documentation required in a regulated environment. The position will report to the VisionGate CTO and may develop into a management role. Some travel may be required.
Roles and Responsibilities
Training and Experience
To apply contact Michael Meyer, meyer@visiongate3d.com
IT Support Engineer
VisionGate Corporation
275 N. Gateway Dr. Phoenix, AZ 85034
VisionGate produces the Cell-CT™, the world’s first 3D cellular imaging device based upon optical projection tomography, which renders cells with sub-micron, isometric resolution. Based on 3D images of cells from sputum, VisonGate aims to improve patient health with the world’s first, non-invasive, diagnostic test for early lung cancer detection: LuCED™. VisionGate is expanding to carry the development and commercialization of its products forward.
Position Summary
VisionGate is currently commercializing its LuCED test for early detection of lung cancer. Development of other tests based on the Cell-CT are being considered or are in progress. To facilitate commercialization of our tests and manage our research IT environment, we seek to add a part-time staff member who will help manage and grow our IT Infrastructure.
Roles and Responsibilities
Training and Experience
To apply contact Rahul Katdare, katdare@visiongate3d.com
Chandler Arizona, May 5, 2014: The Arizona Bioindustry Association today announced that Arizona’s life science industry will be showcased on June 19, 2014 at the Scottsdale Conference Center and Resort during the AZBio Expo. Continue reading
A path to 21st century cures being mapped by the Senate Energy and Commerce CommitteeContinue reading
Flagship Biosciences’ custom image analysis development leverages Leica Biosystems’ strong installed base in digital pathology
Mayo Clinic launches ‘YOU ARE … THE CAMPAIGN FOR MAYO CLINIC’ to perpetuate medical care research and educationContinue reading